Eli Lilly and Company completes acquisition of Versanis Bio

Bimagrumab is presently being evaluated in BELIEVE Phase IIb trial alone and also in combination with semaglutide in adults who are overweight or obese. Credit: Joachim Schnürle from Pixabay.